In vitro activity of an essential oil against Leishmania donovani

Phytotherapy Research

Volumn 21, Issue 11, 2007, Pages 1055-1058

  Monzote, L ^a   Garcia M ^a   Montalvo, A M ^a   Scull, R ^b   Miranda, M ^b   Abreu, J ^b  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b INSTITUTO DE FARMACIA Y ALIMENTOS   (Cuba)

Author keywords

Amastigote; Chenopodium ambrosioides; Leishmania donovani; Macrophage; Promastigote

Indexed keywords

CHENOPODIUM AMBROSIOIDES EXTRACT; ESSENTIAL OIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHENOPODIUM AMBROSIOIDES; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; FEMALE; GROWTH INHIBITION; IN VITRO STUDY; LEISHMANIA DONOVANI; NONHUMAN; PHAGOCYTOSIS;

ANIMALS; CHENOPODIUM AMBROSIOIDES; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; OILS, VOLATILE;

CHENOPODIUM AMBROSIOIDES; LEISHMANIA DONOVANI;

EID: 36549087686     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2210     Document Type: Article

References (33)

1. Berman J. 2003. Current treatment approaches to leishmaniasis. Curr Opin Infect Dis 16: 397-401.
2. Bodley AL, McGarry MW, Shapiro TA. 1995. Drug cytotoxicity assay for African trypanosomes and Leishmania species. J Infect Dis 172: 1157-1159.
3. Brendle JJ, Outlaw A, Kumar A et al. 2002. Antileishmanial activities of several classes of aromatic dications. Antimicrob Agents Chemother 46: 797-807.
4. Caio E, Lima D, Kaplan MAC, Nazareth M, Rossi-Bergmann B. 1999. Selective effect of 2′,6′-dihydroxy-4′methoxychalcone isolated from Piper aduncum on Leishmania amazonensis. Antimicrob Agents Chemother 43: 1234-1241.
5. Chan-Bacab MJ, Peña-Rodríguez LM. 2001. Plant natural products with leishmanicidal activity. Nat Prod Rep 18: 674-688.
6. Chibale K, Visser M, Yardley Y, Croft SL, Fairlamb AH. 2000. Synthesis and evaluation of 9,9-dimethylxanthene tricycles against Trypanothione reductase, Trypanosoma brucei, Trypanosoma cruzi and Leishmania donovani. Bioorg Med Chem Lett 10: 1147-1150.
7. Croft SL, Snowdon D, Yardley V. 1996. The activities of four anticancer alkyllysophospholipids against L. donovani, Trypanosoma cruzi and Trypanosoma brucei. J Antimicrob Chemother 38: 1041-1047.
8. Croft SL, Yardley V, Kendrick H. 2002. Drug sensitivity of Leishmania species: some unresolved problems. Trans R Soc Trop Med Hyg 96: S1/127-S1/129.
9. Delorenzi JC, Attias M, Gattass CR et al. 2001. Antileishmanial activity of an indole alkaloid from Peschiera australis. Antimicrob Agents Chemother 45: 1349-1354.
10. Desjeux P. 2001. The increased in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 95: 239-243.
11. Edzard E. 1998. Harmless herbs? A review of the recent literature. Am J Med 104: 170-178.
12. Ephros M, Bitnum A, Shaked P, Waldman E, Zilberstein D. 1999. Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes. Antimicrob Agents Chemother 43: 278-282.
13. Espuelas S, Legrand P, Loiseau PM, Bories C, Barratt G, Irache JM. 2000. In vitro reversion of amphotericin B resistance in Leishmania donovani by poloxamer 188. Antimicrob Agents Chemother 44: 2190-2192.
14. Franca F, Lago EL, Marsden PD. 1996. Plant used in the treatment of leishmanial ulcers due to Leishmania (Viannai braziliensis in an endemic area of Bahia, Brazil. Rev Soc Bras Med Trop 29: 229-232.
15. Gadano A, Gurni A, Lopez P, Ferraro G, Carballo M. 2002. In vitro genotoxic evaluation of medicinal plant Chenopodium ambrosioides. J Ethnopharmacol 81: 11-16.
16. Giove NRA. 1996. Traditional medicine in the treatment of enteroparasitosis. Rev Gastroenterol Peru 16: 197-202.
17. Guerin PJ, Olliaro P, Sundar S, Boelvaert M, Croft SL, Desjeux P. 2002. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and proposed research and development agenda. Lancet Infect Dis 2: 494-501.
18. Herwaldt BL. 1999. Leishmaniasis. Lancet 354: 1191-1199.
19. Iwu MM, Jackson JE, Schuster BG. 1994. Medicinal plants in the fight against leishmaniasis. Parasitol Today 10: 65-68.
20. Kiuchi F, Itano Y, Uchiyama N et al. 2002. Monoterpene hydroperoxides with trypanocidal activity from Chenopodium ambrosioides. J Nat Prod 65: 509-512.
21. MacMahon-Pratt D. 2004. Mechanism of pathogenesis differences amongst Leishmania species. Scientific Working Group Report on Leishmaniasis, TDRnews Special Programme for Research and Training in Tropical Diseases. Geneva, Switzerland, 2-4 February.
22. Maes L, Vanden D, Germonprez N et al. 2004. In vitro and in vivo activities of a triterpenoid saponin extract (PX-6518) from the plant Maesa balansae against visceral Leishmania species. Antimicrob Agent Chemother 48: 130-136.
23. Mikus J, Harkenthal M, Steverding D, Reichling J. 2000. In vitro effect of essential oils and isolated mono- and sesquiterpenes on Leishmania major and Trypanosoma brucei. Planta Med 66: 366-368.
24. Monzote L, Montalvo AM, Almanonni AS, Scull R, Miranda M, Abreu J. 2006. Activity of the essential oil from Chenopodium ambrosioides grown in Cuba against Leishmania amazonensis. Chemotherapy 52: 130-136.
25. Monzote L, Sariego I, Montalvo AM, Garrido N, Scull R, Abreu J. 2004. Propiedades antiprotozoarias de aceites esenciales extraídos de plantas cubanas. Rev Cub Med Trop 56: 230-233.
26. Pare PW, Zajicek J, Ferracini VL, De Melo TS. 1993. Antifungal terpenoids from Chenopodium ambrosioides. Biochem Syst Ecol 21: 649-653.
27. Perez-Victoria FJ, Castanys S, Gamarro F. 2003. Leishmania donovani resistance to meltifosine involves a defective inward translocation of the drug. Antimicrob Agent Chemother 47: 2397-2403.
28. Pollack Y, Segal R, Golenser J. 1990. The effect of ascaridole on the in vitro development of Plasmodium falciparum. Parasitol Res 76: 570-572.
29. Quinlan MB, Quinlan RJ, Nolan JM. 2002. Ethnophysiology and herbal treatment of intestinal worms in Dominica, West Indies. J Ethnopharmacol 80: 75-83.
30. Rates SMK. 2001. Plants as source of drugs. Toxicon 39: 603-613.
31. Tiuman TS, Ueda-Nakamura T, Aparício D et al. 2005. Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium. Antimicrob Agent Chemother 49: 176-182.
32. Vizoso A, García A, Ramos A, Piloto J, Pavón V, Penichet M. 2000. Evaluación mutagénica de un extracto fluído con un menstruo etanólico al 70% de Teloxis ambrosiodes L. weber (Apasote). Rev Cub Plant Med 5: 102-105.
33. Wang L, Carrasco C, Kumar C et al. 2001. Evaluation of the influence of compound structure on stacked-dimer formation in the DNA minor groove. Biochemistry 40: 2511-2521.